NF-E2 related factor 2 (Nrf2) is a CNC/b-zip protein that regulates antioxidant response element (ARE)-mediated expression, and antioxidant induction, of detoxifying enzyme genes, including NAD(P)H:quinone oxidoreductase1 (NQO1). A comparison of Nrf2 from dierent species, and with other b-zip proteins, revealed the presence of a highly conserved cysteine residue at position 506 in the DNA binding domain of Nrf2. Sitedirected mutagenesis was used to mutate this cysteine to serine. Transfection/over expression experiments in human hepatoblastoma (Hep-G2) cells demonstrated that mutant Nrf2 (mNrf2), containing the C506S mutation, was signi®cantly less ecient in activating ARE-mediated gene expression, and induction in response to tert-butyl hydroquinone (t-BHQ), as copmpared with wild-type Nrf2. N-ethyl malemide (NEM), a sulfhydryl crosslinker, inhibited Nrf2 but not mNrf2C506S-mediated expression of NQO1. This further implicated the cysteine at position 506 in Nrf2 regulation of ARE-mediated gene expression. Nuclear localization experiments revealed that C506S mutation did not aect the retention of Nrf2 by INrf2/Keap1 in the cytosol, or its release in response to antioxidants. However, band and supershift assays showed a signi®cant reduction in the binding of mNrf2C506S to the NQO1 gene ARE as compared with wild-type Nrf2. Therefore, the C506S mutation in Nrf2 lowered its anity for the ARE, leading to decreased expression, and antioxidant induction, of NQO1.
Introduction
Cellular oxidative stress is caused by a variety of external and internal stimuli, including xenobiotics and antioxidants , in¯am-mation (Thelen et al., 1993) , ionizing radiation (Breen and Murphy, 1995) , and cellular respiration (Grisham and McCord, 1986) . These stimuli result in the production of free radicals, including reactive oxygen species (ROS). ROS, and xenobiotic and antioxidant generated electrophiles, attack DNA and other cellular macromolecules, causing aging, neurodegenerative diseases, arthritis, arteriosclerosis, and tumor induction and promotion (Breen and Murphy, 1995; Grisham and McCord, 1986; Ward, 1994; Rosen et al., 1995) . Cells have developed a defense mechanism to detoxify and remove electrophiles and ROS. During times of electrophilic and oxidative stress, a battery of detoxifying genes is coordinately induced through the antioxidant response element (ARE) (Rushmore and Pickett, 1993; Jaiswal, 1994) . These genes include NAD(P)H:quinone oxidoreductases (NQOs), which compete with cytochromes P450 and P450 reductase and catalyze two-electron reductive metabolism and detoxi®cation of quinones (Joseph et al., 1994; Radjendirane et al., 1997; Talalay et al., 1995; Riley and Workman, 1992; Ernster, 1987) ; glutathione S-transferases (GSTs), which conjugate hydrophobic electrophiles and ROS with glutathione (Pickett and Lu, 1989; Tsuchida and Sato, 1992) ; UDP-glucuronosyl transferases (UDP-GT), which catalyze the conjugation of glucuronic acid with xenobiotics and drugs, leading to their excretion (Tephly and Burchell, 1990) ; epoxide hydrolase (EH), which inactivates epoxides (Oesch et al., 1991) ; g-glutamylcysteine synthetase (g-GCS), which plays a role in glutathione metabolism (Mulkahy et al., 1997) ; ferritin-L gene, which plays an important role in iron storage (Wasserman and Fahl, 1997) ; and heme oxygenase-1 (HO-1), which catalyses the ®rst and rate-limiting step in heme catabolism (Choi and Alam, 1996) .
In response to xenobiotic and antioxidant stress, Nrf2, a basic leucine zipper transcription factor (bZIP), binds to the ARE and positively regulates AREmediated induction of detoxifying genes, including NQO1 (Venugopal and Jaiswal, 1996) . Nrf2 is also known to regulate ARE-mediated expression and induction of GST Ya, g-GCS and HO-1 genes (Venugopal and Jaiswal, 1996; Nguyen et al., 2000; Jayepaul and Jaiswal, 2000; Wild et al., 1999; Alam et al., 1999) . Under normal conditions, Nrf2 is held in the cytoplasm by a cytosolic inhibitor INrf2/KEAP1 (Itoh et al., 1999; Dhakshinamoorthy and Jaiswal, 2001) . When cells are challenged by oxidative stress, Nrf2 is released from INrf2/Keap1 and translocates to the nucleus, where it activates transcription. The signal, which causes this release and activates Nrf2, is not clearly understood. Nrf2 has been shown to heterodimerize with c-Jun and small Maf proteins (MafG and MafK). These heterodimeric complexes bind to the ARE, and alter ARE-mediated gene expression (Venugopal and Jaiswal, 1998; Itoh et al., 1997; Nguyen et al., 2000; Wild et al., 1999) .
bZIP proteins, including c-Jun and c-Fos, contain a highly conserved cysteine in their DNA binding domains (Abate et al., 1990) . This cysteine residue has been shown to be a site of redox regulation in c-Jun, aecting its binding to the AP1 site (Abate et al., 1990) . Interestingly, all species of Nrf2 also contains this cysteine residue in their DNA binding region (Venugopal and Jaiswal, 1998) . In addition, it has been reported that ARE-mediated expression and induction of the NQO1 gene is sensitive to sulfhydryl modifying agents (Li and Jaiswal, 1994) . The present studies were performed to determine the role of this cysteine residue in Nrf2 regulation of ARE-mediated gene expression, and induction in response to antioxidants and xenobiotics.
In this report, we show that site-directed mutagenesis of cysteine to serine in the DNA binding domain of Nrf2 leads to a signi®cant decrease in the capacity of Nrf2 to upregulate ARE-mediated NQO1 gene expression, and induction in response to t-BHQ. The C506S mutation did not aect Nrf2 interaction with INrf2/ Keap1. This mutation also had no eect on the heterodimerization of Nrf2 with MafG, or the binding of the Nrf2/MafG complex to the NQO1 gene ARE. However, binding of the mNrf2/c-Jun complex to the ARE was signi®cantly reduced as compared to Nrf2-c-Jun. Therefore, the cysteine at position 506 of Nrf2 is required for interaction with speci®c heterodimeric partner proteins and/or binding of these heterodimeric complexes to the ARE.
Results
The cysteine residue at position 506 of Nrf2 was successfully converted to a serine residue using site directed mutagenesis. The molecule created, Nrf2C506S, is referred to as mNrf2 (Figure 1 ). Over expression of either wild-type Nrf2 or mNrf2 in HepG2 cells lead to a dose dependent increase in ARE activity (Figure 2a) . However, the activity of mNrf2 was substantially lower than that of the wild-type Nrf2 at all the three concentration of the plasmid used for transfection. The transfection of Hep-G2 cells with 0.15 mg of pcDNA-Nrf2 plasmid led to more than 100% increase in ARE-mediated CAT gene expression. However, the replacement of pcDNA-Nrf2 with similar amount of pcDNA-mNrf2 in the same experiment resulted in 25% repression of ARE-mediated CAT gene expression. The other two concentrations of the expression plasmids also showed signi®cant dierences between the eciency of Nrf2 and mNrf2 to upregulate ARE-mediated CAT gene expression. This dierence in activity was not due to a dierence in the amount of expression. HepG2 cells transfected with V5 tagged Nrf2, or mNrf2, were lysed with RIPA buer, 100 mg of the whole cell extracts were resolved on an SDS ± PAGE. Western blots were performed with the V5 antibody and demonstrated equal expression of the two proteins in transfected Hep-G2 cells (Figure 2b ).
To determine if mNrf2 would respond to antioxidants, both wild-type Nrf2 and mNrf2 were transiently transfected into HepG2 cells. The cells were then treated with 100 mM or 200 mM t-BHQ for 16 h. mNrf2 activity was induced in response to 100 mM t-BHQ treatment, but again the response was attenuated as compared to wild-type Nrf2 (Figure 3 ). 200 mM t-BHQ treatment caused an inhibition of Nrf2 activity. mNrf2, however, was still induced by 200 mM t-BHQ treatment.
N-ethyl malemide (NEM) was used to determine if C506, in Nrf2, is a target for oxidation-reduction (redox) regulation. Hep-G2 cells cotransfected with the reporter plasmid, NQO1 ARE-tk-CAT, expression plasmid pcDNA, or pcDNA-Nrf2 were treated with 0.25 mM or 0.5 mM NEM. These cells showed a signi®cant repression of ARE-mediated CAT expression (Figure 4 ). However, in a similar experiment, the mNrf2 regulation of ARE-mediated CAT expression was more or less unaected after treatment with NEM.
GFP tagged proteins were used to show the interaction of Nrf2/mNrf2 with INrf2 ( Figure 5 ). The transfection of QT6 cells, with EGFP-Nrf2 or EGFPmNrf2 led to the expression of the respective proteins in both the cytosolic and nuclear compartments ( Figure 5 , left panels). The treatment of transfected QT6 cells with DMSO had no eect on the localization of Nrf2 or mNrf2 (data not shown). The coexpression of INrf2 with EGFP-Nrf2 or EGFP-mNrf2 retained the respective proteins in the cytosol ( Figure 5 , middle panels). The treatment of these cells with t-BHQ caused the release of Nrf2, or mNrf2, which then translocated to the nucleus ( Figure 5 , right panels).
Nrf2, mNrf2, MafG-V5 and c-Jun were in vitro translated; the translation was con®rmed by SDS ± PAGE ( Figure 6b ) and Western analysis (data not shown). These proteins were used in band and super shift assays. Nrf2-c-Jun heterodimers, MafG-V5 homodimers and Nrf2/mNrf2-MafG-V5 heterodimers all bound to the NQO1 gene ARE (Figures 6 and 7 ). Nrf2-c-Jun binding to the ARE required pretreatment with cytosolic extract, as reported earlier (Venugopal and Jaiswal, 1998) . The endogenous proteins in the cytosolic extract created a slight background. This was taken into account when analysing the results. Densitometric analysis of the Nrf2-c-Jun and mNrf2-c-Jun bands revealed nearly a threefold decrease in binding of mNrf2-c-Jun to the ARE as compared to wild-type Nrf2-c-Jun, P5.025 (Figure 6a ,b). Equimolar concentrations of Nrf2 and mNrf2 were used in the band shift assays as demonstrated by autoradiography of the in vitro translated proteins ( Figure 6c ). The results also demonstrated that both Nrf2 and mNrf2 were in vitro transcribed and translated with equal eciencies (Figure 6c ).
The band shift experiments with NQO1 gene ARE and in vitro translated Nrf2, mNrf2 and MafG-V5 revealed binding of MafG-V5-MafG-V5 homodimers and Nrf2-MafG-V5 and mNrf2-MafG-V5 heterodimers to the ARE (Figure 7 ). The super shift assays with V5 antibody super shifted the MafG-MafG homo-and Nrf2-MafG hetrodimeric complexes with the NQO1 gene ARE (Figure 7) . However, the analysis of the shifted and super shifted bands did not show a dierence between binding of Nrf2-MafG-V5 and mNrf2-MafG-V5.
The band shift experiments were also performed with nuclear extracts from Hep-G2 cells over expressing Nrf2 or mNrf2 (data not shown). No dierence was detected. This presumably was because of relatively lower proportion of Nrf2 and mNrf2 proteins, compared to AP1-binding proteins. It may be noteworthy that the NQO1 gene ARE contains a perfect AP1 (Jun+Fos) binding site (Jaiswal, 1994) . Therefore, we believe that the dierence in binding between Nrf2 and mNrf2 in the in vivo band shift was masked due to binding of AP1, and related proteins, to the ARE.
Discussion
Nrf2, a cap`n'collar containing b-zip protein, has a clearly established role in the ARE-mediated expression, and induction, of NQO1 and other detoxifying enzyme genes . Nrf2 mediated activation of detoxifying enzymes is considered essential for cellular protection against oxidative stress and other free radical damage . Normally, Nrf2 is retained in the cytosol by an inhibitor protein, INrf2/Keap1 (Itoh et al., 1999; Dhakshinamoorthy and Jaiswal, 2001 ). The treatment of cells with antioxidants and xenobiotics causes Nrf2 to be released from INrf2/Keap1. Nrf2 then translocates to the nucleus and activates AREmediated expression of NQO1 and other detoxifying enzyme genes.
It may be noteworthy that Nrf2 does not bind to the ARE by itself, but must heterodimerize with another b-zip protein before binding to the ARE. c-Jun has been shown to heterodimerize with Nrf2 in the presence of an unknown cytosolic factor(s) and upregulate ARE activity (Venugopal and Jaiswal, 1998) . Small Maf proteins, including MafG, also form heterodimers with Nrf2 and bind to the ARE (Itoh et al., 1997; Nguyen et al., 2000; Wild et al., 1999; . However, the in vivo role of Nrf2-MafG heterodimers is controversial; some groups suggest that the heterodimers activate, while others suggest that they repress AREmediated gene expression Wild et al., 1999; Itoh et al., 1997; Gong et al., 2001) . Clearly, the role of b-zip proteins that heterodimerize with Nrf2 and participate in Nrf2 signaling is not completely understood.
An analysis of the DNA binding domain of Nrf2 revealed the presence of a cysteine residue that was conserved across the species, and in other members of the Nrf family, including Nrf1 and Nrf3. A similar cysteine residue in c-Jun has been shown to be a site of redox regulation. Mutation of this site led to a signi®cant alteration in the expression of c-Jun target genes (Abate et al., 1990) . A mutant Nrf2 molecule, containing a cysteine to serine mutation at position 506 in its DNA binding domain, was generated by sitedirected mutagenesis. The C506S change in Nrf2 signi®cantly reduced the ability of Nrf2 to activate ARE-mediated gene expression, and induction in response to antioxidants. In addition, mNrf2 regulation of ARE-mediated gene expression demonstrated resistance to NEM inhibition, as compared to wild-type Nrf2. These results demonstrate the importance of cysteine 506 in redox regulation of Nrf2. This is also supported by previous observations that AREmediated gene expression is sensitive to sulfhydryl modifying agents, such as glutathione, and related molecules (Li and Jaiswal, 1994; Bergelson et al., 1994; Shertzer et al., 1995) .
Further experiments demonstrated that the reduced eciency of mNrf2 to activate ARE-mediated gene expression was not due to alterations in its interaction with INrf2/Keap1, but due to its reduced binding with the ARE. We demonstrated that, like wild-type Nrf2, mNrf2 interacted with, and was retained in the cytosol by, INrf2/Keap1. Furthermore, mNrf2, like Nrf2, was released from INrf2 in response to antioxidants, and Hep-G2 cells were transfected with pcDNA-Nrf2-V5 or pcDNA-mNrf2-V5. Forty-eight hours after transfection the cells were harvested and whole cell extracts were made using RIPA buer. 100 mg of the extracts were resolved on a 10% PAGE, and Western blots were performed with V5 antibodies and b-actin antibodies
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D Bloom et al translocated to the nucleus. However, mNrf2-c-Jun heterodimers bound about threefold less eciently to the ARE than wild-type Nrf2-c-Jun, causing the decrease in ARE activation. A dierence in binding between mNrf2-MafG and wild-type Nrf2-MafG, with the ARE, was not observed. This may be due to structural and functional dierences between c-Jun and MafG.
In conclusion, the cysteine at position 506 in the DNA binding region of Nrf2 is required for AREmediated activation of detoxifying genes, and their induction in response to antioxidants. This cysteine appears to be redox regulated, and is required for ecient binding of Nrf2 to the ARE. The exposure of cells to chemicals leads to the generation of electrophilic and oxidative signals . It is possible that these signals lead to the modi®cation of the cysteine in the DNA binding region of Nrf2. This results in increased binding of Nrf2 to the ARE, and activation of ARE-mediated gene expression. This pathway has to be in addition to the phosphorylation of Nrf2 as reported earlier . It is expected that a redox factor(s), like Ref-1, plays a role in the regulation of cysteine 506 (Yao et al., 1994) . However, the role of such factors in the redox regulation of Nrf2 remains a topic for further study.
Materials and methods

Plasmid construction/mutagenesis
The previously constructed LNCX-Nrf2 plasmid (Venugopal and Jaiswal, 1996) containing the mouse Nrf2 cDNA was mutated using the Transformer TM Site-Directed Mutagenesis Kit (2nd version) from Clontech. The cysteine at position 506, in the DNA binding domain of Nrf2, was mutated to a serine, Figure 3 Nrf2C506S mutation diminishes t-BHQ induction of ARE-mediated NQO1 gene expression. Hep-G2 cells were cotransfected with 0.5 mg of reporter plasmid, NQO1 gene ARE-tk-CAT, and 0.15 mg of pcDNA (expression vector alone), pcDNANrf2, or pcDNA-mNrf2. Thirty-six hours after the transfection, the cells were treated with 100 mM or 200 mM t-BHQ for 16 h. The cells were harvested at the end of the treatment and analysed for CAT activity. The results are presented as fold-induction in CAT activity in response to t-BHQ. The data are mean+s.d. of ®ve independent transfection experiments using the protocol provided by Clontech. Brie¯y described, two Oligos were synthesized. The ®rst, AJ203, was designed to replace the appropriate bases to change the cysteine (TGT) to serine (AGC). The second, AJ204, was designed to remove a unique restriction site, Nru1, in the LNCX plasmid. The LNCX-Nrf2 plasmid was denatured by boiling for 3 min in the presence of AJ203 and AJ204. The mixture was allowed to cool and the new (mutant) strand was synthesized using T4 DNA polymerase on T4 DNA Ligase. Digesting with Nru1 linearized the non-mutated DNA. The mutated plasmids were then chemically transformed into BMH 71-18 mutS (repairde®cient) E. coli. The cells were grown overnight in 5 ml LB medium containing ampicillin. 1.5 ml of the overnight culture was used to prepare a mini-prep by the boiling-lysis method described in the Clontech manual. Again the plasmid DNA was digested with Nru1 to linearize any unmutated plasmids, and transformed into mutS E coli. The bacteria were grown on LB agar containing ampicillin. Twelve colonies were analysed by restriction digest, and nine appeared to have been successfully mutated. The mutation was con®rmed by sequencing. The wild-type Nrf2 and mutated Nrf2 cDNA's (Nrf2C506S) were then subcloned separately into the pcDNA3.1/V5-HIS TOPO vector, via PCR and TA cloning to generate pcDNA-Nrf2 and pcDNA-mNrf2 plasmids respectively. These constructs produce proteins with the V5 epitope. Clones were also generated that do not have the V5 tag. The V5 epitope contains 14 amino acids in the sequence: Gly-Lys-Pro-Ile-Pro-Asn-Pro-Leu-LeuGly-Leu-Asp-Ser-Thr. The antibodies against V5 are commercially available from Invitrogen, California. The construction of the hARE-tk-CAT plasmid has been previously described (Xie et al., 1995) . Primer Sequences for Site Directed Mutagenesis of Nrf2: AJ203: 5' GCC GCC CAG AAC AGC AGG AAA AGG AAG 3' AJ204: 5' GAT CCC CTC GAG AGT TGG TTC Mouse wild-type Nrf2 and mNrf2 were subcloned separately at Kpn I/Apa I sites of pEGFP vector to produce pEGFP-Nrf2 and pEGFP-mNrf2 respectively. These plasmids generate EGFP tagged Nrf2 and EGFP tagged INrf2 in transfected cells. The rat INrf2 cDNA encoding the fulllength INrf2 protein and the chicken MafG cDNA were subcloned in pcDNA vector to generate pcDNA-INrf2 and pcDNA-MafG plasmids by described procedures (Dhakshinamoorthy and Jaiswal, 2001 ). The MafG cDNA was also subcloned in-frame with the V5 epitope of the pcDNA expression plasmid as previously described (Dhakshinamoorthy and Jaiswal, 2000). These plasmids encode the V5 tagged MafG (MafG-V5) protein upon transfection in mammalian cells.
Cell culture and cotransfection of reporter and expression plasmids
Human Hepatoblastoma (Hep-G2) and Quail Fibroblast (QT6) cells were grown in monolayer cultures in six well dishes, as described (Li and Jaiswal, 1992; Dhakshinamoorthy and Jaiswal, 2001) . QT6 cells are known to express lesser amount of INrf2 that retains Nrf2 in the cytosol (Dhakshinamoorthy and Jaiswal, 2001) . Therefore, a portion of the Nrf2 is always in the nucleus. 0.5 mg of reporter plasmid, hARE-tk-CAT, was mixed with dierent concentrations of expression plasmid pcDNA3.1 vector alone or pcDNA-Nrf2, pcDNA-mNrf2, and cotransfected in Hep-G2 cells using the CalPhos TM Mammalian Transfection Kit from P-labeled NQO1 gene ARE was incubated with in vitro translated Nrf2 or mNrf2 alone or in combination with in vitro translated c-Jun, and band shift analysis performed by procedures as described in Materials and methods. CE alone lane also contained rabbit reticulocyte lysate to normalize with other lanes. (b) The density of the bands was determined using Kodak imaging software. The graph represents data from three independent experiments+s.d. A one tailed student t-test was performed. (c) 5 ml of the in vitro translated Nrf2 and mNrf2 proteins were resolved on a SDS ± PAGE, treated with Amplify solution to enhance the 35 S signal, dried and exposed to X-ray ®lm. The two proteins were translated with equal eciency. CE, cytosolic extract; *non-speci®c reticulocyte band Clontech by procedures supplied by the manufacturer. 0.5 mg of Rous sarcoma virus (RSV)-b-galactosidase (b-gal) plasmid was added to each transfection to normalize transfection eciency. The transfected cells were treated with various concentrations of tert-butylhydroquinone (t-BHQ) and N-ethylmalamide (NEM) at 36 h post-transfection. The cells were harvested 48 h after transfection in the reporter lysis buer supplied with the CAT enzyme assay system from Promega. The b-galactosidase activity was determined using the assay system from Promega. The appropriate amounts of cell extract, calculated based on b-galactosidase activity, were then used to perform the CAT Assay using Promega's liquid scintillation method.
The transfection of Hep-G2 cells with pcDNA-Nrf2 and pcDNA-mNrf2 resulted similar expression of the respective proteins as determined by Western analysis ( Figure 2B ). Whole cell extracts were prepared using RIPA buer, and 100 mg of the extracts were run on SDS ± PAGE. Western blots were then performed with the V5 antibody, and b-actin antibody as a control. NEM and t-BHQ were obtained from Sigma, St. Louis, MO, USA. b-actin antibodies were purchased from CalBiochem.
Nuclear localization
The nuclear localization studies of the EGFP-tagged Nrf2 and EGFP-tagged mNrf2 protein molecules were performed in QT6 cells. This is because QT6 cells are de®cient in INrf2 and a suitable model to study Nrf2 nuclear localization (Dhakshinamoorthy and Jaiswal, 2001) . The QT6 cells were grown on Lab-Tek II Chamber Slides (Nalge Nunc International, Naperville, IL, USA). Half a microgram of plasmids pEGFP-Nrf2 and pEGFP-mNrf2 were transfected either alone or in combination with pcDNA-INrf2 using the Eectene Transfection Reagent Kit by procedures as described in manufacturer's protocol. After 36 h of transfection, the cells were washed twice with 16PBS. Then the chamber was removed from the slide and a cover slip was placed over it. The slide was observed under the ZEISS uorescent microscope by excitation at 488 nm, and the images were captured by described procedures (Chan et al., 1999) . The pictures were taken using the Kodak select black and white ®lm on a Nikon UFX camera. For induction studies, the cells were treated with 50 mM t-BHQ dissolved in DMSO for 16 h. The cells treated with the vehicle (DMSO) alone were included as control in all induction experiments
In vitro transcription/translation
The in vitro transcription/translation of the plasmids encoding Nrf2, mNrf2 (Nrf2C506S), c-Jun and MafG were performed using the TNT coupled rabbit reticulocyte lysate systems (Promega) by procedures as suggested in the manufacturer's protocol. Redivue L-[
35 S] Methionine was Figure 7 Nrf2C506S-c-Jun and Nrf2-c-Jun heterodimers bind with similar eciency to the NQO1 gene ARE. The NQO1 gene ARE was 32 P-labeled. 100 000 c.p.m. of labeled ARE was incubated with in vitro translated Nrf2 or mNrf2 alone or in combination with MafG-V5 and band shift analysis performed by procedures as described in Materials and methods. In related experiments, the band shift mixture was incubated with V5 antibodies and band shift experiment was performed. SB, Super shifted band, *nonspeci®c reticulocyte band substituted for methionine in the reactions. After the coupled transcription/translation, the proteins were resolved using SDS ± PAGE. Brie¯y, 5 ml of the translated proteins were resolved on a 10% gel, treated with Amplify solution (NAMP 100, Amersham Pharmacia) to enhance the 35 S signal, dried and exposed to X-ray ®lm.
Preparation of nuclear and cytosolic extract
The nuclear extract from human hepatoblastoma (Hep-G2) cells over expressing Nrf2 and mNrf2 were prepared by procedures as described (Venugopal and Jaiswal, 1998) . To prepare cytosolic extract, 106100 mm dishes of Hepal cells were grown to 80% con¯uency. The cells were washed with ice cold PBS without calcium or magnesium, then each plate was scraped into 10 ml PBS. The cells were pelletted and resuspended in 10 volumes of isotonic buer (0.15 M NaCl, 1.5 mM MgCl 2 , 10 mM Tris-HCl pH 7.4, NP-40 0.5% (v/v), 1 mM DTT, and 1 mM PMSF. DTT and PMSF were added just before use). The cells were dounced 10 times using a loose pestle, and spun at 3500 r.p.m. for 10 min to remove cell debris. The supernatant was spun again for 1 h at 14 000 r.p.m., and then dialyzed against the DNA binding buer (20 mM HEPES pH 7.9, 50 mM KCl, 1 mM EDTA, 1 mM DTT, 1 mM PMSF, and 10% glycerol. DTT and PMSF were added just before use).
Band and super shift assays
The NQO1 gene ARE (Nucleotide Sequence 5'-CAG TCA CAG TGA CTC AGC AGA ATC T-3') was end labeled with gP 32 ATP and T4 polynucleotide kinase. The labeled ARE was incubated with nuclear extracts or in vitro translated proteins. Band and super shift assays were then performed by previously described procedures (Venugopal and Jaiswal, 1998; . Ten micrograms of the nuclear extract or equimolar concentrations of in vitro translated proteins were used in the gel shift and super shift experiments. 1.5 ml of anti-V5 antibody, 3 ml of Nrf2 antibody or pre-immune serum, were used in the super shift assays. Densitometry anylysis was done using Kodak 1D image analysis software version 3.5.
Abbreviations NQO1, First isoform of cytosolic NAD(P)H:quinone oxidoreductase1; ARE, antioxidant response element; t-BHQ, tert-butyl hydroquinone; CAT, chloramphenicol acetyl transferase.
